NFKB1 and colorectal carcinoma: EGCG induces p21 expression by enhancing p21 promoter activity (8), releases adenosine by disrupting the folic acid cycle (9), and inhibits CRC cell proliferation (10) and migration (11) by the NF-κB signaling pathway.